Search results for " facility" in Articles / App Notes
Article
Single-Use Technologies Prove Effective for Viral Vector Process Development
These advantages, according to Atul Mohindra, senior director of R&D for Lonza, drive down overall contamination rates as well as enhance the efficiency of a production facility while reducing manufac…
Article
Regulatory Requirements for Safe and Efficient Biologic Drug Development
FDA cutback on routine facility inspections due to pandemic related travel restrictions. And we've even seen some drug approvals delayed due to difficulties in inspecting manufacturing sites.
W…
Article
Process Development: 2020 Reflections and 2021 Possibilities
The challenges posed by the COVID-19 pandemic in 2020 brought about many unprecedented lessons and promising developments in the biopharmaceutical industry. Last year in particular reenforced the ne…
Article
Testa Challenge 2020 Attracts Leading International Bioprocessing Innovators
Held over an intensive week in the Testa Center located at Cytiva´s Uppsala site, a unique biomanufacturing scale-up facility, the Testa Challenge aims to allow start-ups, research groups and companie…
Article
Next Generation Process Chromatography
If we consider highly efficient multi-tonne processes like the blockbusters of today, then the cost of goods of the process and facility output are already highly efficient. The cost efficiency of mAb…
Article
Improving Upstream Predictability
Some of the latest biopharmaceutical manufacturing facility designs have cell culture and some purification unit operations take place in one location, notes Mohindra.
At the same time, the …
Article
A Successful First Year for Testa Center
The facility is an initiative between the Swedish Government and Cytiva to support collaboration between the public sector, business, and academia, and to boost the commercialization of new technologi…
Article
Cell-Culture Advances Test Bioreactor Performance Models
…crease in the media volumes required, which has logistical and cost implications for a manufacturing facility, adds Mistretta.
Overall, perfusion mode generally places higher performance demand…
Article
The Good and Bad of Biosimilars
One key to success is to consider facility size, particulary before you have something on the market.
Learn more about a more modular and flexible approach:
Read full article || Watch vid…
Article
Scaling Up Novel Therapies
In addition, they permit some degree of facility design standardization, improving operational flexibility and capital savings, he says.
Developers are exploring how these platforms might…